CoChat

Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications

The DOI matches its Crossref record; 155 of the 156 references it cites were found in a registry or an index.

Abstract

Much of the biopharmaceutical industry's success over the past 30 years has relied on products derived from Chinese Hamster Ovary (CHO) cell lines. During this time, improvements in mammalian cell cultures have come from cell line development and process optimization suited for large-scale fed-batch processes. Originally developed for high cell densities and sensitive products, perfusion processes have a long history. Driven by high volumetric titers and a small footprint, perfusion-based bioprocess research has regained an interest from academia and industry. The recent pandemic has further highlighted the need for such intensified biomanufacturing options. In this review, we outline the technical history of research in this field as it applies to biologics production in CHO cells. We demonstrate a number of emerging trends in the literature and corroborate these with underlying drivers in the commercial space. From these trends, we speculate that the future of perfusion bioprocesses is bright and that the fields of media optimization, continuous processing, and cell line engineering hold the greatest potential. Aligning in its continuous setup with the demands for Industry 4.0, perfusion biomanufacturing is likely to be a hot topic in the years to come.

Overview

Integrity signals

Registry

Crossref · 10.1080/07388551.2021.1998821

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 155 references

Research works printed but not linked: 1

  1. Lee SH, 2002, J Microbiol Biotechnol, 12, 457

Cited by

See all 55

Metadata

Authors
MacDonald, M. A., Nöbel, M., Roche Recinos, D., Martínez, V. S., Schulz, B. L., Howard, C. B., Baker, K., Shave, E., Lee, Y. Y., Marcellin, E., Mahler, S., Nielsen, L. K., & Munro, T.
Affiliations
  • The University of Queensland (AU)
  • ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Brisbane, Australia
  • Thermo Fisher Scientific, Woolloongabba, Brisbane, Australia
  • CSL (Australia) (AU)
Corresponding author
Munro, Trent
Venue
Critical Reviews in Biotechnology
Published
2021-11-29
Volume
42
Issue
7
Pages
1099-1115
ISSN
  • 0738-8551 (ISSN-L)
  • 1549-7801
OpenAlex
W3215495644
Cited by
55
References
156
Citations by year
2026: 13 · 2025: 12 · 2024: 15 · 2023: 10 · 2022: 5
FWCI
0.79
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
Funders
  • Australian Research Council
  • Novo Nordisk Foundation (NNF10CC1016517, NNF14OC0009473)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
  • Physical Sciences › Chemical Engineering › Fluid Flow and Transfer Processes › Fluid Dynamics and Mixing
Keywords
perfusion culture, CHO cells, biopharmaceutical manufacturing, continuous bioprocessing, cell line engineering, culture medium optimization, Industry 4.0
MeSH terms
Animals, Biological Products, Cricetulus, Cricetinae, Perfusion, CHO Cells, Bioreactors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications. https://app.cochat.ai/papers/10.1080/07388551.2021.1998821
The paper
MacDonald, M. A., Nöbel, M., Roche Recinos, D., Martínez, V. S., Schulz, B. L., Howard, C. B., Baker, K., Shave, E., Lee, Y. Y., Marcellin, E., Mahler, S., Nielsen, L. K., & Munro, T. (2022). Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications. Critical Reviews in Biotechnology. https://doi.org/10.1080/07388551.2021.1998821

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.